Cargando…

The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma

SIMPLE SUMMARY: Primary central nervous system lymphoma (PCNSL) is a rare form of cancer and the treatment of newly diagnosed patients is challenging. Many chemotherapy regimens are being used, and methotrexate is an important component in most. The role of the immunotherapy rituximab is not as clea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Dijck, Ruben, Doorduijn, Jeanette K., Bromberg, Jacoline E.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074001/ https://www.ncbi.nlm.nih.gov/pubmed/33923396 http://dx.doi.org/10.3390/cancers13081920

Ejemplares similares

The Role of Rituximab in Primary Central Nervous System Lymphoma
por: Bromberg, Jacoline E. C., et al.
Publicado: (2020)

Primary therapy and survival in patients over 70 years old with primary central nervous system lymphoma: a contemporary, nationwide, population-based study in the Netherlands
por: van der Meulen, Matthijs, et al.
Publicado: (2020)

Conditional relative survival in primary central nervous system lymphoma: a population-based study in the Netherlands
por: Dinmohamed, Avinash G, et al.
Publicado: (2020)

MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma
por: van der Meulen, Matthijs, et al.
Publicado: (2021)

Extent of radiological response does not reflect survival in primary central nervous system lymphoma
por: van der Meulen, Matthijs, et al.
Publicado: (2021)

Multi-scale spatial modeling of immune cell distributions enables survival prediction in primary central nervous system lymphoma
por: Roemer, Margaretha G.M., et al.
Publicado: (2023)

Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma
por: Murakami, Mineko, et al.
Publicado: (2011)

Flow cytometry shows added value in diagnosing lymphoma in brain biopsies
por: van der Meulen, Matthijs, et al.
Publicado: (2018)

Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma
por: Zhao, Defeng, et al.
Publicado: (2014)

Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma
por: Sun, Xuefei, et al.
Publicado: (2017)

Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience
por: Suleman, Adam, et al.
Publicado: (2022)

Primary Central Nervous System Lymphoma
por: Dong, Yan-Hong, et al.
Publicado: (2016)

Primary central nervous system lymphoma
por: Gloghini, Annunziata, et al.
Publicado: (2015)

Primary central nervous system lymphoma
por: Löw, Sarah, et al.
Publicado: (2018)

Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma
por: Yuan, Xianggui, et al.
Publicado: (2022)

ML-20 Outcome of high-dose methotrexate-based chemotherapy with or without Rituximab for primary central nervous system lymphoma
por: Takezaki, Tatsuya, et al.
Publicado: (2020)

Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis
por: Batara, Julette Marie F, et al.
Publicado: (2022)

Second-line treatment for primary central nervous system lymphoma
por: Reni, M, et al.
Publicado: (1999)

Recent Advances in Treatment of Primary Central Nervous System Lymphoma
por: Nayak, Lakshmi, et al.
Publicado: (2013)

Editorial: Advances in the treatment of primary central nervous system lymphoma
por: Qian, Liren, et al.
Publicado: (2023)

Primary cardiac lymphoma with central nervous system relapse
por: van Rooijen, Cleo R., et al.
Publicado: (2017)

Primary intercavernous lymphoma of the central nervous system
por: Dultra, Arthur Henrique de Aquino, et al.
Publicado: (2015)

Primary Central Nervous System Lymphoma With Systemic Recurrence
por: Pandravada, Sasirekha, et al.
Publicado: (2021)

Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma
por: Wu, Susan Y, et al.
Publicado: (2023)

Role of Positron Emission Tomography in Primary Central Nervous System Lymphoma
por: Rozenblum, Laura, et al.
Publicado: (2022)

Interstitial pneumonitis during rituximab-containing chemotherapy for primary central nervous system lymphomas: a case report and review of literature
por: Wu, Yuchen, et al.
Publicado: (2018)

P1223: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE STUDY OF THE ZRMA REGIMEN（ZANUBRUTINIB, RITUXIMAB, METHOTREXATE AND CYTARABINE)
por: Tang, Y.
Publicado: (2022)

PB2315: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE STUDY OF THE ZR OR ZRM REGIMEN (ZANUBRUTINIB, RITUXIMAB, METHOTREXATE)
por: Teng, Yue, et al.
Publicado: (2023)

Treatment outcome in children with central nervous system-positive Burkitt lymphoma using only intrathecal and systemic chemotherapy combined with rituximab
por: Huang, Shuang, et al.
Publicado: (2021)

High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy
por: Harada, Sakiko, et al.
Publicado: (2021)

Advances in the treatment of newly diagnosed primary central nervous system lymphomas
por: Qian, Liren, et al.
Publicado: (2017)

Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment()
por: Cai, Qingqing, et al.
Publicado: (2019)

Mutational analysis of primary central nervous system lymphoma
por: Bruno, Aurélie, et al.
Publicado: (2014)

Unusual relapse of primary central nervous system lymphoma
por: Igala, Marielle
Publicado: (2016)

Radiation Therapy for Primary Central Nervous System Lymphoma
por: Shibamoto, Yuta
Publicado: (2013)

Advances in Pathobiology of Primary Central Nervous System Lymphoma
por: Yang, Xue-Liang, et al.
Publicado: (2017)

Primary peripheral T-cell central nervous system lymphoma
por: Bird, Cylaina E., et al.
Publicado: (2021)

ML-14 LOW INVASIVE APPROACH FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA TREATMENT INVOLVING RITUXIMAB–METHOTREXATE + PROCARBAZINE + VINCRISTINE AND TRIPLE INTRATHECAL INJECTION
por: Ogawa, Takahiro, et al.
Publicado: (2019)

Are there primary intraocular lymphomas that do not develop into central nervous system lymphomas?
por: Matsuo, Toshihiko, et al.
Publicado: (2019)

Primary intraventricular central nervous system lymphoma in an immunocompetent patient
por: Suri, Vinit, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n7hr397am93cctsrinmngf20ns